Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2025-05-23 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业（集团）股份有限公司关于公司董事长收到中国证券监督管理委员会陕西监管局《行政处罚事先告知书》的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding the receipt of an administrative penalty prior notice from the China Securities Regulatory Commission (CSRC) Shaanxi Bureau addressed to the company's chairman. It details the investigation, alleged violations related to information disclosure, and the proposed administrative penalty. The document explicitly states it is a public announcement about the chairman receiving the administrative penalty prior notice and includes risk disclosures about the impact on the company. There are no financial statements, audit results, or detailed financial data presented. The document length is short (1649 characters), and it serves as a regulatory announcement about legal and compliance matters involving the chairman, not a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-05-23 Chinese
金花企业（集团）股份有限公司股东减持计划时间届满暨减持股份结果公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the completion of a shareholder's share reduction plan, detailing the number of shares reduced, the time period, and the results of the reduction. It includes specific data about shareholding percentages before and after the reduction, the method of reduction (centralized bidding), and confirms the plan's implementation status. This type of document is a notification about changes in major shareholding levels, specifically a shareholder reducing their stake below a 5% threshold. It is not a financial report, earnings release, or management discussion, but a formal disclosure of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief report publication announcement or a regulatory filing fallback. Confidence is high due to clear match with the MRQ definition.
2025-05-20 Chinese
陕西博硕律师事务所关于金花企业（集团）股份有限公司2024年年度股东大会的法律意见书
AGM Information Classification · 100% confidence The document is a legal opinion letter from a law firm regarding the 2024 Annual General Meeting (AGM) of Jinhua Enterprise (Group) Co., Ltd. It details the procedures for convening and holding the AGM, the qualifications of attendees, the agenda items, the voting procedures, and the voting results. The document explicitly states it is a legal opinion on the AGM's legality and procedures, not the AGM materials themselves or the annual report. The document is about the AGM event and its legal validation, which fits the category of AGM Information (AGM-R). The document length is 8009 characters, which is substantial and contains detailed AGM-related content, not just an announcement or a brief notice. Therefore, the correct classification is AGM Information (AGM-R).
2025-05-15 Chinese
金花企业（集团）股份有限公司2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the annual report, board and supervisory reports, financial statements, profit distribution, auditor appointment, and executive remuneration. It includes attendance details, voting percentages, and legal witness statements confirming the validity of the meeting and voting process. The document does not contain the full annual report or financial statements themselves but reports on the meeting outcomes and voting results. The document length is 3680 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-15 Chinese
金花企业（集团）股份有限公司关于参加“2025年陕西辖区上市公司投资者集体接待日暨2024年度业绩说明会”的公告
Investor Presentation Classification · 85% confidence The document is an announcement about the company's participation in an upcoming investor collective reception day and 2024 annual performance explanation meeting. It details the date, time, format (online platform), participants, and how investors can join and ask questions. It does not contain actual financial statements or detailed financial analysis but rather serves as a notice for an event where such information might be discussed. The document length is short (1190 characters) and it is clearly an announcement of an event related to an earnings or performance explanation meeting, not the meeting materials or transcript itself. Therefore, it fits best under the category of Investor Presentation (IP), as it is a detailed presentation for investors focusing on financials, strategy, and market position, or more precisely, an announcement of such a presentation. However, since it is an announcement of the event rather than the presentation itself, and given the options, the closest and most appropriate classification is Investor Presentation (IP).
2025-05-13 Chinese
金花企业（集团）股份有限公司关于金天格胶囊获批国家中药保护品种延长保护期的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the approval and extension of protection period for a specific pharmaceutical product by the National Medical Products Administration. It contains no financial data, no mention of financial results, no shareholder voting results, no management changes, no legal proceedings, no capital or financing updates, and no regulatory certifications. The document is an official announcement about a regulatory approval related to product protection, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or others. It is a regulatory announcement about product protection status. Given the content and length (730 characters), it is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-04-30 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.